Target intelligence / Profile preview

Zinc finger and BTB domain-containing protein 12 (ZBTB12)

Target
ZBTB12
Molecular classification
Transcription factor, Zinc finger protein, BTB/POZ domain-containing protein
01

Overview

Zinc finger and BTB domain-containing protein 12 (ZBTB12) is a nuclear transcription factor containing a BTB/POZ domain and C2H2 zinc finger motifs. It binds DNA in a sequence-specific manner to negatively regulate transcription via RNA polymerase II, and plays a crucial role in human pluripotent stem cell fate by preventing dedifferentiation and enabling proper differentiation into the three germ layers. ZBTB12 acts as a molecular barrier, repressing primate-specific endogenous retroviruses (notably HERVH) and their associated long non-coding RNAs, such as LINC-ROR and ESRG, to ensure unidirectional cell fate transition. The protein is evolutionarily conserved across vertebrates and predominantly localized in the nucleoplasm. Genetic dysfunction of ZBTB12 skews stem cells toward increased self-renewal at the expense of differentiation, highlighting its role in balancing cellular identity and developmental progression; in disease, it is associated with rare conditions such as malignant ovarian cyst and testicular infarct, and may participate in tumorigenic processes.

Other names
ZBTB12C6orf46Protein G10Bat9D6S59EG10NG35HLA-B-associated transcript 9
02

Mechanism of action

Not applicable. No drugs directly target ZBTB12.

03

Biological functions

Negative regulation of transcription by RNA polymerase IIFine-tuning the expression of endogenous retroviral elements (specifically HERVH)Balancing stem cell self-renewal and differentiationSafeguarding cell fate unidirectionality during stem cell differentiationRegulation of cytokine productionRegulation of immune system processes
04

Disease associations

Cancer (suggested association; specific roles have not been deeply characterized)Testicular infarctMalignant ovarian cystDevelopmental biology: pivotal for successful germ layer differentiation and prevention of dedifferentiation in pluripotent stem cellsOther (potential links to developmental and differentiation defects)
05

Safety considerations

No notable safety concerns are directly associated with therapeutic targeting; absence of direct drug interaction precludes established risksGenetic disruption may impact differentiation and development
06

Biomarkers

ZBTB12 expression could be a potential biomarker for differentiation status in pluripotent stem cells

Beyond the preview

Go deeper on Zinc finger and BTB domain-containing protein 12 (ZBTB12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and BTB domain-containing protein 12 (ZBTB12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call